Effectiveness of COVID-19 vaccines in pregnant women and their infants
COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants
This study looks at how well COVID-19 vaccines work for pregnant women and their babies, focusing on preventing infections and hospital visits, while also finding out what helps or hinders pregnant women from getting vaccinated.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11045601 on NIH RePORTER |
What this research studies
This research investigates how effective COVID-19 vaccines are for pregnant women and their infants. It aims to determine the vaccine's ability to prevent COVID-19 infections and hospitalizations in pregnant women, as well as its effectiveness in protecting infants during their first year of life. The study will also explore vaccination rates among pregnant women and identify factors that influence whether they choose to get vaccinated. By gathering this information, the research seeks to provide clearer guidance on COVID-19 vaccination during pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women who are considering or have received a COVID-19 vaccine.
Not a fit: Patients who are not pregnant or who do not plan to become pregnant may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide critical insights into the safety and effectiveness of COVID-19 vaccines for pregnant women and their infants, potentially leading to improved health recommendations.
How similar studies have performed: While there have been studies on COVID-19 vaccine effectiveness in general populations, this specific focus on pregnant women and infants is relatively novel and has not been extensively tested.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Zerbo, Ousseny — Kaiser Foundation Research Institute
- Study coordinator: Zerbo, Ousseny
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.